NextPlat enters exclusive distribution deal with OPKO Health for China Alibaba Tmall platform

NextPlat Corp

Exclusive right to market and resell OPKO health and veterinary products in China via Alibaba.
Agreement effective October 12, 2023, initial term of one year, auto-renews unless 90-day notice.
Distributor bears all credit risk; Supplier retains ownership until full payment.
Minimum purchase volumes and turnover plan set forth in Schedule 3 (redacted in filing).
Distributor to handle product registration in China; Supplier provides required certifications.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

NextPlat Corp entered into Distribution Agreement with OPKO HEALTH Spain, S.L.U. valued at Exclusive distributor in China for OPKO health and veterinary products (effective 2023-10-12).

Action: entry
Agreement: supply
Counterparty: OPKO HEALTH Spain, S.L.U.
Value: Exclusive distributor in China for OPKO health and veterinary products
Effective: 2023-10-12

Exact text from the filing

As previously disclosed, on October 12, 2023, NextPlat Corp (the "Company") entered into a Distribution Agreement with OPKO HEALTH Spain, S.L.U. (“OPKO”) to market and resell certain OPKO health and veterinary products (the "Products") through the Alibaba platform in China (the "Distribution Agreement").

View on SEC.gov

280 material agreements filed in the last 30 days. Browse all material agreements →

NextPlat Corp filing history →

Source: SEC EDGAR

accession 0001437749-23-028516

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.